PDX1 and pancreatic adenocarcinoma: Based on this, an evaluation of a mouse TF-targeting ADC in the clinically relevant LSL-KrasG12D/+; LSL-Trp53R172H/+; PDX-1-Cre (KPC) model of pancreatic adenocarcinoma was undertaken [128].